LEAP THERAPEUTICS, INC. (LPTX)

Latest Insider Confidence Score

2025Q4

44.9
Bearish

Company insider confidence (by quarter)

2017Q1 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
McEvoy William Patrick III — 8,283,761 Nov 20, 2025
Winklevoss Cameron Howard — 5,616,906 Nov 21, 2025
Winklevoss Tyler Howard — 5,616,906 Nov 21, 2025
Winklevoss Capital Fund, LLC — 5,616,906 Nov 21, 2025
Winklevoss Treasury Investments, LLC — 5,616,906 Nov 21, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 23, 2025 Dec 30, 2025 LI WILLIAM Director Neutral 52.5 - 0.00% ✗ -
Dec 23, 2025 Dec 30, 2025 Richard Christian M Director Neutral 52.5 - 0.00% ✗ -
Dec 23, 2025 Dec 30, 2025 Mashiach Nissim Director Neutral 52.5 - 0.00% ✗ -
Dec 23, 2025 Dec 30, 2025 Martin Patricia A. Director Neutral 52.5 - 0.00% ✗ -
Dec 23, 2025 Dec 30, 2025 Schilsky Richard Director Neutral 52.5 - 0.00% ✗ -
Dec 23, 2025 Dec 30, 2025 LOSCALZO JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Dec 23, 2025 Dec 30, 2025 CAVANAUGH JAMES H Director Neutral 52.5 - 0.00% ✗ -
Dec 26, 2025 Dec 30, 2025 Dietz Thomas John Director Sell 46.3 -35,000 -42.17% ✗ $42K
Dec 23, 2025 Dec 30, 2025 McEvoy William Patrick III Chief Investment Officer Neutral 52.5 - 0.00% ✗ -
Dec 23, 2025 Dec 30, 2025 Mirabelli Christopher Director Neutral 47.5 -1,424 -6.18% ✗ -
Dec 23, 2025 Dec 30, 2025 ONSI DOUGLAS E CEO Neutral 47.5 -1,424 -1.32% ✗ -
Dec 23, 2025 Dec 30, 2025 Oei Khing Djien Director Neutral 52.5 - 0.00% ✗ -
Oct 8, 2025 Nov 21, 2025 Winklevoss Capital Fund, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Nov 21, 2025 Winklevoss Capital Fund, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Nov 20, 2025 McEvoy William Patrick III Chief Investment Officer Neutral 52.5 - 0.00% ✗ -
Nov 17, 2025 Nov 19, 2025 Mirabelli Christopher Director Sell 17.5 -676,319 -60.60% ✗ $2.1M
Nov 17, 2025 Nov 19, 2025 CAVANAUGH JAMES H Director Sell 20.0 -261,840 -99.92% ✗ $822.2K
Nov 17, 2025 Nov 19, 2025 ONSI DOUGLAS E CEO Sell 17.5 -676,319 -56.30% ✗ $2.1M
Nov 11, 2025 Nov 13, 2025 ONSI DOUGLAS E CEO Neutral 52.5 - 0.00% ✗ -
Nov 11, 2025 Nov 13, 2025 LI WILLIAM Director Neutral 52.5 - 0.00% ✗ -
Nov 11, 2025 Nov 13, 2025 Richard Christian M Director Neutral 52.5 - 0.00% ✗ -
Nov 11, 2025 Nov 13, 2025 Mashiach Nissim Director Neutral 52.5 - 0.00% ✗ -
Nov 11, 2025 Nov 13, 2025 Martin Patricia A. Director Neutral 52.5 - 0.00% ✗ -
Nov 11, 2025 Nov 13, 2025 Schilsky Richard Director Neutral 52.5 - 0.00% ✗ -
Nov 11, 2025 Nov 13, 2025 LOSCALZO JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Nov 11, 2025 Nov 13, 2025 CAVANAUGH JAMES H Director Neutral 52.5 - 0.00% ✗ -
Nov 11, 2025 Nov 13, 2025 Mirabelli Christopher Director Neutral 52.5 - 0.00% ✗ -
Nov 11, 2025 Nov 13, 2025 Dietz Thomas John Director Neutral 52.5 - 0.00% ✗ -
Nov 11, 2025 Nov 13, 2025 Oei Khing Djien Director Neutral 52.5 - 0.00% ✗ -
Nov 13, 2025 Oei Khing Djien Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2025 Baum Jason Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jul 1, 2025 LAWLOR AUGUSTINE COO Neutral 52.5 - 0.00% ✗ -
Jul 1, 2025 O'Mahony John Mark Chief Manufacturing Officer Neutral 52.5 - 0.00% ✗ -
Mar 28, 2025 Apr 1, 2025 ONSI DOUGLAS E CEO Neutral 52.5 - 0.00% ✗ -
Mar 28, 2025 Apr 1, 2025 Granfield Christine VP, Head of Reg Affairs/Qual Sell 47.5 -6,604 -29.35% ✗ $2.1K
Mar 28, 2025 Apr 1, 2025 Baum Jason Chief Scientific Officer Sell 47.5 -6,604 -29.35% ✗ $2.1K
Mar 28, 2025 Apr 1, 2025 LAWLOR AUGUSTINE COO Sell 47.5 -7,797 -1.10% ✗ $2.5K
Mar 28, 2025 Apr 1, 2025 O'Mahony John Mark Chief Manufacturing Officer Neutral 52.5 - 0.00% ✗ -
Mar 28, 2025 Apr 1, 2025 Mirabelli Christopher Chair Sell 50.0 -6,672 -0.94% ✗ $2.1K
Mar 28, 2025 Apr 1, 2025 Sirard Cynthia Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Nov 13, 2024 Nov 15, 2024 CAVANAUGH JAMES H Director Neutral 52.5 - 0.00% ✗ -
Nov 13, 2024 Nov 15, 2024 ONSI DOUGLAS E CEO Neutral 52.5 - 0.00% ✗ -
Nov 13, 2024 Nov 15, 2024 LAWLOR AUGUSTINE COO Neutral 52.5 - 0.00% ✗ -
Nov 13, 2024 Nov 15, 2024 Mirabelli Christopher Chair Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 Granfield Christine VP, Head of Reg Affairs/Qual Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 Sirard Cynthia Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 Schilsky Richard Director Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 Richard Christian M Director Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 Martin Patricia A. Director Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 ONSI DOUGLAS E CEO Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 LOSCALZO JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 LI WILLIAM Director Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 O'Mahony John Mark Chief Manufacturing Officer Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 LAWLOR AUGUSTINE COO Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 Dietz Thomas John Director Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 CAVANAUGH JAMES H Director Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 Mirabelli Christopher Director Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 Baum Jason Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 Mashiach Nissim Director Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 Mashiach Nissim Director Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 Dietz Thomas John Director Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 Schilsky Richard Director Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 Granfield Christine VP, Head of Reg Affairs/Qual Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 Baum Jason Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 Richard Christian M Director Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 O'Mahony John Mark Chief Manufacturing Officer Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 Sirard Cynthia Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 Martin Patricia A. Director Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 LAWLOR AUGUSTINE COO Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 LOSCALZO JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 Mirabelli Christopher Chair Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 ONSI DOUGLAS E CEO Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 LI WILLIAM Director Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 CAVANAUGH JAMES H Director Neutral 52.5 - 0.00% ✗ -
Jan 26, 2024 Jan 30, 2024 Mirabelli Christopher Chair Neutral 52.5 - 0.00% ✗ -
Jan 26, 2024 Jan 30, 2024 O'Mahony John Mark Chief Manufacturing Officer Neutral 52.5 - 0.00% ✗ -
Jan 26, 2024 Jan 30, 2024 Sirard Cynthia Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 26, 2024 Jan 30, 2024 LAWLOR AUGUSTINE COO Neutral 52.5 - 0.00% ✗ -
Jan 26, 2024 Jan 30, 2024 ONSI DOUGLAS E CEO Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 Dietz Thomas John Director Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 LI WILLIAM Director Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 Martin Patricia A. Director Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 LAWLOR AUGUSTINE COO Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 Mashiach Nissim Director Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 Richard Christian M Director Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 Mirabelli Christopher Chair Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 ONSI DOUGLAS E CEO Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 Schilsky Richard Director Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 CAVANAUGH JAMES H Director Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 Granfield Christine VP, Head of Reg Affairs/Qual Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 O'Mahony John Mark Chief Manufacturing Officer Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 Baum Jason Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 Sirard Cynthia Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 LOSCALZO JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2023 Apr 4, 2023 Mirabelli Christopher Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2023 Apr 4, 2023 Sirard Cynthia Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 31, 2023 Apr 4, 2023 O'Mahony John Mark Chief Manufacturing Officer Neutral 52.5 - 0.00% ✗ -
Mar 31, 2023 Apr 4, 2023 Granfield Christine VP, Head of Reg Affairs/Qual Neutral 52.5 - 0.00% ✗ -
Mar 31, 2023 Apr 4, 2023 LOSCALZO JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2023 Apr 4, 2023 LI WILLIAM Director Neutral 52.5 - 0.00% ✗ -